Cargando…

Garcinia cambogia Ameliorates Non-Alcoholic Fatty Liver Disease by Inhibiting Oxidative Stress-Mediated Steatosis and Apoptosis through NRF2-ARE Activation

Excessive free fatty acids (FFAs) causes reactive oxygen species (ROS) generation and non-alcoholic fatty liver disease (NAFLD) development. Garcinia cambogia (G. cambogia) is used as an anti-obesity supplement, and its protective potential against NAFLD has been investigated. This study aims to pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Joo-Hui, Park, Min-Ho, Myung, Chang-Seon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388869/ https://www.ncbi.nlm.nih.gov/pubmed/34439474 http://dx.doi.org/10.3390/antiox10081226

Ejemplares similares

Garcinia cambogia—A Supplement-Related Liver Injury
por: Calaquian, Loreto L, et al.
Publicado: (2022)

Diuretic Activity of Leaves of Garcinia Cambogia in Rats
por: Mathew, Githa E, et al.
Publicado: (2011)

Hepatotoxicity associated with Garcinia cambogia: A case report
por: Yousaf, Muhammad Nadeem, et al.
Publicado: (2019)

Acute Severe Liver Injury Related to Long-Term Garcinia cambogia Intake
por: Ferreira, Victor, et al.
Publicado: (2020)

Acute Pancreatitis Secondary to Use of Appetite Suppressant: Garcinia cambogia
por: Iqbal, Umair, et al.
Publicado: (2019)

Quality Evaluation of Dietary Supplements for Weight Loss Based on Garcinia cambogia
por: Mena-García, Adal, et al.
Publicado: (2022)

Statistical Design of Sustained-Release Tablet Garcinia cambogia Extract and Bioconverted Mulberry Leaf Extract for Anti-Obesity
por: Lee, Hye-Jin, et al.
Publicado: (2020)

Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation
por: Lunsford, Keri E, et al.
Publicado: (2016)

Acute Hepatitis due to Garcinia Cambogia Extract, an Herbal Weight Loss Supplement
por: Sharma, Akshay, et al.
Publicado: (2018)

Interaction of Garcinia cambogia (Gaertn.) Desr. and Drugs as a Possible Mechanism of Liver Injury: The Case of Montelukast
por: Di Giacomo, Silvia, et al.
Publicado: (2023)

Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients
por: Al-kuraishy, Hayder M., et al.
Publicado: (2016)

Weight Loss or Liver Loss: A Case Report on Fulminant Hepatic Failure Secondary to Garcinia cambogia Supplementation
por: Le, Danny, et al.
Publicado: (2023)

Does Glycine max leaves or Garcinia Cambogia promote weight-loss or lower plasma cholesterol in overweight individuals: a randomized control trial
por: Kim, Ji-Eun, et al.
Publicado: (2011)

Hepatotoxicity Associated with Use of the Weight Loss Supplement Garcinia cambogia: A Case Report and Review of the Literature
por: Kothadia, Jiten P., et al.
Publicado: (2018)

Arousal-Inducing Effect of Garcinia cambogia Peel Extract in Pentobarbital-Induced Sleep Test and Electroencephalographic Analysis
por: Kim, Duhyeon, et al.
Publicado: (2021)

La Garcinia cambogia (Tamarido malabar) y el Ácido hidroxicítrico en la reducción de peso: /
por: Morales Garrido, Ricardo Ignacio
Publicado: (2016)

Garcinia cambogia Phenolics as Potent Anti-COVID-19 Agents: Phytochemical Profiling, Biological Activities, and Molecular Docking
por: Aati, Hanan Y., et al.
Publicado: (2022)

Garcinia cambogia Extract Increased Hepatic Levels of Lipolysis-Stimulated Lipoprotein Receptor and Lipids in Mice on Normal Diet
por: Hanse, Marine, et al.
Publicado: (2023)

Liver Transplantation for Fulminant Hepatic Failure Precipitated by Pheochromocytoma Crisis in the Setting of Using Garcinia cambogia Weight Loss Supplement: A Case Report
por: Selim, Motaz A, et al.
Publicado: (2023)

Combination of Garcinia cambogia Extract and Pear Pomace Extract Additively Suppresses Adipogenesis and Enhances Lipolysis in 3T3-L1 Cells
por: Sharma, Kushal, et al.
Publicado: (2018)

Gut microbiota Modulated by Probiotics and Garcinia cambogia Extract Correlate with Weight Gain and Adipocyte Sizes in High Fat-Fed Mice
por: Heo, Jaeyoung, et al.
Publicado: (2016)

Garcinia cambogia water extract alleviates insulin resistance and hepatic lipid accumulation in mice fed a high-fat diet
por: Dong, Jinya, et al.
Publicado: (2023)

Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease
por: Wang, Huan, et al.
Publicado: (2023)

Therapeutic Effect of Garcinia cambogia Extract and Hydroxycitric Acid Inhibiting Hypoxia-Inducible Factor in a Murine Model of Age-Related Macular Degeneration
por: Ibuki, Mari, et al.
Publicado: (2019)

Long-term effects of Garcinia cambogia/Glucomannan on weight loss in people with obesity, PLIN4, FTO and Trp64Arg polymorphisms
por: Maia-Landim, Andrea, et al.
Publicado: (2018)

Combination of Lactobacillus plantarum HAC03 and Garcinia cambogia Has a Significant Anti-Obesity Effect in Diet-Induced Obesity Mice
por: Kang, Youn-Goo, et al.
Publicado: (2023)

Effects on the Human Body of a Dietary Supplement Containing L-Carnitine and Garcinia cambogia Extract: A Study using Double-blind Tests
por: Yonei, Yoshikazu, et al.
Publicado: (2008)

Dose Dependent Effects of Aqueous Extract of Garcinia cambogia Desr. Against Letrozole Induced Polycystic Ovarian Syndrome in Female Adult Rats With Possible Mechanisms Exploration
por: Rana, Saba, et al.
Publicado: (2023)

Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis
por: Rafiei, Hossein, et al.
Publicado: (2023)

Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease
por: Zhao, Ruifang, et al.
Publicado: (2020)

Recent Advances in Garcinia cambogia Nutraceuticals in Relation to Its Hydroxy Citric Acid Level. A Comprehensive Review of Its Bioactive Production, Formulation, and Analysis with Future Perspectives
por: H. Baky, Mostafa, et al.
Publicado: (2022)

Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice
por: Takahara, Ikuko, et al.
Publicado: (2017)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021)

Betaine in ameliorating alcohol-induced hepatic steatosis
por: Rehman, Aisha, et al.
Publicado: (2021)

Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease
por: Mukai, Takako, et al.
Publicado: (2017)

Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice
por: Takahara, Ikuko, et al.
Publicado: (2020)

Dihydroartemisinin ameliorates the liver steatosis in metabolic associated fatty liver disease mice by attenuating the inflammation and oxidative stress and promoting autophagy
por: Hu, Yiyi, et al.
Publicado: (2023)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Quinoa Ameliorates Hepatic Steatosis, Oxidative Stress, Inflammation and Regulates the Gut Microbiota in Nonalcoholic Fatty Liver Disease Rats
por: Zhong, Lingyue, et al.
Publicado: (2023)

Ganoderma lucidum Ameliorates Non-Alcoholic Steatosis by Upregulating Energy Metabolizing Enzymes in the Liver
por: Jung, Soonwoong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_98jqgkf25kf50jregn6r3sdpjd